united

What You Should Know Before Watching Vice’s Special About Curing Cancer

Stephen Grupp, of the Children’s Hospital of Philadelphia, Emily Whitehead, and Vice CEO Shane Smith.Tomorrow night at 10 pm on the east and west coasts of the United States, Vice, the TV arm of the fast-growing Vice media empire, will air a special on HBO that posits that scientists are closing in on a cure for cancer.“Today in real time […]

3 Tiny Biotech Stocks That I'm Paying Attention to in 2015

The fact that biotech stocks can trade up or down significantly based on news from clinical research trials ensures there is no shortage of pop-and-drop stories in this business. The industry’s volatility might scare off many investors, but for those willing to accept the risk, here are three tiny biotech stocks that could make big moves thanks to the release […]

The Seven Financial Indicators of Highly Successful Biotech Stocks …

The Seven Financial Indicators of Highly Successful Biotech Stocks InvestingCompanies / BioTechFeb 21, 2015 – 10:41 AM GMTBy: Money_MorningErnie Tremblay writes: When evaluating biotech stocks, many key indicators that work for other industries – e.g. price-to-earnings ratio, profit margin, revenue-per-share – often don’t apply.Here’s why they don’t, and why seven of these critical financial indicators do…The Usual Ratios Don’t ApplyThe […]

STTG Market Recap Jan 30, 2015 – Stock Trading To Go

It remains a time for caution.  After a brief flurry of optimism this Monday the rest of the week went quite badly.  Friday the indexes opened mixed, sold off until mid day, tried to rally til mid afternoon, and then a flurry of selling into the close.  Not great.  The S&P 500 fell 1.30% and the NASDAQ 1.03%.   A lower […]

'Heroes or zeroes': Tread carefully in Canadian biotech sector

A survey of investable Canadian sectors will eventually lead back to biotechnology, a corner of the market sure to elicit some well-deserved skepticism.With U.S. biotech stocks setting a torrid pace over the last several years, some of the hype was bound to spread to Canada, which has seen a recent uptick in biotech listings.More Related to this Story
Under fire, marijuana […]

RayVa Patent Award Sends Apricus Biosciences Inc (APRI) Stock …

Healthcare

RayVa Patent Award Sends Apricus Biosciences Inc (APRI) Stock Trading Up

Apricus Biosciences announces on Tuesday that it has been awarded Rayva’s Patent by USPTO; stock soars by 15.58%
APRI

By: Martin BlancPublished: Jan 28, 2015 at 11:41 am EST

Apricus Biosciences Inc. (NASDAQ:APRI) is trading up by around 15.58% as of 11:14 AM EST. The buying spree on the stock followed the announcement […]

Will Collapse in Oil Price Cause a Stock Market Crash? – Oil-price.net

Will Collapse in Oil Price Cause a Stock Market Crash? By TOM THERRAMUS AND STEVE AUSTIN for OIL-PRICE.NET, 2015/01/14The Black Monday stock market crash of October 19th, 1987 was the largest one-day percentage decline in the Dow Jones Industrial Average. The crash was a genuinely perplexing event. To informed observers it seemed to have little basis in economic fundamentals. There […]

Pharma, Biotech Stocks Avoid Much Of Early New Year’s Malaise

In other news, a Food and Drug Administration advisory panel will meet Wednesday to decide whether to recommend approval for a biosimilar drug, which represents a potentially cheaper alternative to Amgen Inc. ’s Neupogen. If it gains agency approval, this drug would be the first biosimilar to get the FDA’s OK and it could mark the beginning of a new […]

These 3 Biotech Stocks Tripled Investors' Money in 2014

Life-changing financial gains are usually generated over the long haul, not in one year. However, sometimes stocks can put up eye-popping returns over a short period of time and when they do they can have a huge impact on investor’s portfolios. For example, these three healthcare stocks tripled investor’s money last year and while no one can know if they’ll […]

3 Biotech Stocks With a Higher Profit Margin Than Gilead Sciences, Inc.

Source: StockMonkeys.com via Flickr.It’s been a truly transformative year for Gilead Sciences and its shareholders. Even taking into consideration the latest swoon in Gilead’s share price tied to the approval of AbbVie ‘s Viekira Pak and its subsequent multi-year agreement with Express Scripts , Gilead shares are up 25% for the year, essentially doubling the return of the S&P 500 […]